Dr. Reddy's formulations facility received a USFDA Form 483 with four observations following a GMP inspection.

Dr. Reddy's Laboratories LimitedDRREDDY · Filed with the exchange

The company plans to address these findings within the specified timeline, managing potential operational impact.

No comments yet. Be the first.

More from Dr. Reddy's Laboratories Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.